- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02597686
The STAGE Study for Bipolar Disorder
A Pilot Study of a Brief Self-distancing and Perspective Broadening Training Package for Bipolar Disorder
When the investigators are caught up in emotions, it is by stepping back (or decentering) that the investigators are able to see the situation from another perspective. Individuals with emotional disorders, however, can have difficulties in being able to do this.
Research has shown that improving an individual's ability to step back from their emotions and take perspective is possible and can have beneficial effects on depressive symptomatology (Self Distancing and Perspective Broadening [SDPB] training). The SDPB training package involves two techniques: 1) stepping back from situations using mental imagery (building a mental picture of the situation and changing the distance to it) and, 2) reframing situations using perspective broadening reappraisals (giving new meanings to situations). The training package trains these SDPB techniques using an individual's memories and every day events. The fortnightly training comprises of two one to one sessions and daily homework for a week in between.The SDPB training package is aimed at improving an individual's ability to step back from, and put a new meaning to emotional events that take place in their lives.
The prospective pilot study aims to investigate whether the SDPB training package reduces symptomatology and improves these abilities in individuals who experience both depressive and manic episodes (Bipolar Disorder [BD]).
BD has a cumulative lifetime prevalence ranging from 1.52% across Europe and is treated with moderate success using Cognitive Behavioural therapy (CBT). However, 'moderate success' is considerably low compared to other mental health problems and CBT can be time time consuming, expensive, and cognitively demanding (requiring a high level of functioning of one or more cognitive functions). Accordingly, BD may be one of the emotional disorders in greatest need of novel and evidence based treatments.
Studieoversigt
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Norwich, Det Forenede Kongerige, NR4 7TJ
- Rekruttering
- University of East Anglia, Doctorate in Clinical Psychology
-
Kontakt:
- Emma Hill
- E-mail: emma.l.hill@uea.ac.uk
-
Ledende efterforsker:
- Emma Hill, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion criteria include:
- Individuals with a diagnosis of Bipolar Disorder whom are at the time of testing in a euthymic state (not in an episode of depression or mania).
Exclusion criteria include:
- Current substance dependence or abuse
- Current CBT treatment
- Individuals who are not fluent in English
- Organic brain injury
- Active psychotic and manic symptoms requiring hospitalisation
- Active suicidal risk.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: SD-PB training
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The Quick Inventory of Depressive Symptomatology
Tidsramme: 21 days
|
A modified daily measure of depressive symptoms
|
21 days
|
|
The Altman Self Rating Mania Scale
Tidsramme: 21 days
|
A modified daily measure of mania symptoms
|
21 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The Experiences Questionnaire
Tidsramme: over 5 weeks
|
A measure of the ability to decenter
|
over 5 weeks
|
|
The Cognitive Emotion Regulation Questionnaire
Tidsramme: over 5 weeks
|
A measure of the ability to perspective-take
|
over 5 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- UEastAnglia
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Maniodepressiv
-
ProgenaBiomeTrukket tilbageManiodepressiv | Bipolar I lidelse | Bipolar II lidelse | Bipolar type I lidelse | Bipolar lidelse Mild | Bipolar lidelse Moderat | Bipolar lidelse AlvorligForenede Stater
-
Vielight Inc.Ikke rekrutterer endnuBipolar lidelse (BD) | Bipolar | Bipolar lidelse DepressionCanada
-
Xenon Pharmaceuticals Inc.RekrutteringManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar II lidelseForenede Stater
-
Xenon Pharmaceuticals Inc.Tilmelding efter invitationManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar II lidelseForenede Stater
-
University of California, Los AngelesUniversity of Colorado, Denver; University of Pittsburgh; University of Cincinnati og andre samarbejdspartnereRekrutteringTeenagere | Bipolar lidelse (BD) | Bipolar lidelse I eller II | Bipolar lidelse NOS | Bipolar spektrum lidelseForenede Stater
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationAfsluttetManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar lidelse I | Bipolar affektiv lidelseForenede Stater
-
University of Texas Southwestern Medical CenterThe Texas Child Mental Health Care Consortium (TCMHCC)RekrutteringFamiliemedlemmer med bipolar lidelse | Bipolar lidelse (BD) | Bipolar lidelse I eller II | ScreeningsværktøjForenede Stater
-
Joshua RosenblatAfsluttetManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar II lidelseCanada
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SAfsluttetBipolar IForenede Stater, Frankrig, Rumænien, Polen, Canada, Ungarn, Japan, Korea, Republikken, Malaysia, Taiwan
-
Joshua RosenblatAfsluttetManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar II lidelseCanada
Kliniske forsøg med SD-PB training
-
AdvanCell Pty LimitedRekrutteringProstatakræft | Metastatisk kastrationsresistent prostatakræft | Metastatisk hormonfølsom prostatakræftAustralien
-
Molecular Partners AGOrano Med LLCRekrutteringStorcellet neuroendokrint karcinom | Småcellet lungekræft (SCLC) | Ekstrapulmonært neuroendokrint karcinom (EP-NEC) | Storcellepulmonær neuroendokrin carcinom i lungen (LCNEC) | Gastroenteropankreatisk NEC (GEP NEC) | Nekrotiserende enterokolitis i blæren | Andre DLL3-eksprimerende epNECForenede Stater
-
University of South CarolinaDuke University; Kilimanjaro Christian Medical Centre, TanzaniaAfsluttetHIV-testningForenede Stater, Tanzania
-
PegBio Co., Ltd.AfsluttetType 2 diabetes mellitusForenede Stater
-
PegBio Co., Ltd.AfsluttetType 2 diabetes mellitusKina
-
Perspective TherapeuticsRekrutteringSarkom | Hoved- og halskræft | Mavekræft | Kolorektal cancer | Spiserørskræft | Livmoderhalskræft | Mesotheliom | Duktalt adenokarcinom i bugspytkirtlenForenede Stater
-
PegBio Co., Ltd.Afsluttet
-
PegBio Co., Ltd.Afsluttet
-
PegBio Co., Ltd.Afsluttet
-
Assiut UniversityIkke rekrutterer endnu